Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands
- PMID: 16480871
- DOI: 10.1016/j.bmcl.2006.01.011
Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands
Abstract
A series of novel oxyindole-derived HIV-1 protease inhibitors were designed and synthesized based upon our X-ray crystal structure of inhibitor 2 (TMC-114) bound to HIV-1 protease. The effects of substituents, spirocyclic rings, and ring sizes have been investigated. A number of inhibitors exhibited low nanomolar inhibitory potencies against HIV protease.
Similar articles
-
Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.J Med Chem. 2005 May 19;48(10):3576-85. doi: 10.1021/jm050019i. J Med Chem. 2005. PMID: 15887965
-
Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.J Med Chem. 2006 Dec 14;49(25):7342-56. doi: 10.1021/jm060666p. J Med Chem. 2006. PMID: 17149864
-
Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2' side chains.Bioorg Med Chem Lett. 2006 Feb 15;16(4):859-63. doi: 10.1016/j.bmcl.2005.11.011. Epub 2005 Nov 18. Bioorg Med Chem Lett. 2006. PMID: 16298527
-
Nonpeptidic potent HIV-1 protease inhibitors.Drug Des Discov. 1996 Apr;13(3-4):15-28. Drug Des Discov. 1996. PMID: 8874041 Review.
-
Aspects of successful drug discovery and development.Antiviral Res. 2006 Sep;71(2-3):77-89. doi: 10.1016/j.antiviral.2006.05.007. Epub 2006 Jun 8. Antiviral Res. 2006. PMID: 16828174 Review.
Cited by
-
A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro.Antimicrob Agents Chemother. 2007 Jun;51(6):2143-55. doi: 10.1128/AAC.01413-06. Epub 2007 Mar 19. Antimicrob Agents Chemother. 2007. PMID: 17371811 Free PMC article.
-
Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors.Future Med Chem. 2011 Jul;3(9):1181-97. doi: 10.4155/fmc.11.68. Future Med Chem. 2011. PMID: 21806380 Free PMC article. Review.
-
Iodide/H₂O₂ Catalyzed Intramolecular Oxidative Amination for the Synthesis of 3,2'-Pyrrolidinyl Spirooxindoles.Molecules. 2018 Sep 5;23(9):2265. doi: 10.3390/molecules23092265. Molecules. 2018. PMID: 30189635 Free PMC article.
-
Therapeutic Potential of Spirooxindoles as Antiviral Agents.ACS Infect Dis. 2016 Jun 10;2(6):382-92. doi: 10.1021/acsinfecdis.6b00041. Epub 2016 May 5. ACS Infect Dis. 2016. PMID: 27627626 Free PMC article. Review.
-
Enantioselective Synthesis of Spiro[cyclohexane-1,3'-indolin]-2'-ones Containing Multiple Stereocenters via Organocatalytic Michael/Aldol Cascade Reactions.Tetrahedron Lett. 2013 May 8;54(19):2311-2314. doi: 10.1016/j.tetlet.2013.02.030. Tetrahedron Lett. 2013. PMID: 25705059 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information